Can you get medical cannabis for arthritis pain in the UK?

Arthritis pain — from osteoarthritis, rheumatoid arthritis and other inflammatory joint disease — is among the conditions UK private specialists assess. The critical distinction is between treating pain and treating the disease: a cannabis-based medicine does not replace the drugs that protect your joints.

The short answer

  • It is considered for pain relief only, never as a substitute for disease-modifying treatment.
  • No cannabis-based medicine is licensed in the UK for arthritis of any kind.
  • The controlled evidence is one small early trial in rheumatoid arthritis, from 2006.
  • Your rheumatology team should stay involved; inflammatory arthritis needs monitoring regardless.
  • NICE recommends against cannabis-based medicines for chronic pain outside a clinical trial.

Is arthritis pain treated with medical cannabis in the UK?

Arthritis-related pain is assessed by private specialists, typically where pain persists despite proper treatment of the underlying arthritis and where the standard analgesic options have been exhausted or are unsuitable. It is not an NHS treatment for arthritis and is not licensed for it.

Two things need separating. Rheumatoid arthritis and other inflammatory arthritis are driven by an immune process that damages joints over time, and are treated with disease-modifying drugs and biologics that change the course of the disease. Osteoarthritis is a wear-related condition managed with exercise, weight management, physiotherapy, analgesia and sometimes surgery. In both, a cannabis-based medicine is only ever a candidate for symptom relief.

If you have inflammatory arthritis, a specialist will expect you to remain under rheumatology care and to continue your disease-modifying treatment. Stopping it to try something else risks irreversible joint damage.

What the evidence actually shows

The controlled evidence for arthritis is one small early trial, now two decades old, plus indirect evidence from broader chronic pain research. It is a thin base on which to build expectations.

A randomised, double-blind, parallel-group study in Rheumatology gave a THC:CBD oromucosal spray or placebo to 58 patients with rheumatoid arthritis over five weeks. It reported statistically significant improvements in pain on movement, pain at rest, morning stiffness and sleep quality compared with placebo. It was a preliminary study, small, short, and never followed by the large confirmatory trials that would normally be required before a treatment enters routine practice.

For osteoarthritis specifically, controlled evidence is weaker still. Where UK patients with arthritis-related pain are prescribed privately, the rationale is usually drawn from the chronic pain literature rather than from arthritis-specific trials.

The study behind that paragraph

Blake DR, Robson P, Ho M, Jubb RW, McCabe CS. Preliminary assessment of the efficacy, tolerability and safety of a cannabis-based medicine (Sativex) in the treatment of pain caused by rheumatoid arthritis. Rheumatology (Oxford). 2006;45(1):50-52. A randomised, double-blind, placebo-controlled study in 58 patients over five weeks, reporting improvements in pain and morning stiffness. Small, short and preliminary.

Read the paper →

What a specialist will want to see

There is no UK list of qualifying conditions, so nothing here entitles you to a prescription. A specialist works through your history and decides whether a monitored trial is justified for you. For arthritis-related pain they will typically look at:

The general requirements — age, a documented diagnosis, the convention that two standard treatments have been tried, and access to your medical records — are covered in What are the requirements?

Risks and reasons a specialist may say no

The clearest risk in arthritis is not a side effect: it is the temptation to substitute a symptom treatment for disease control. Inflammatory arthritis that is left untreated damages joints permanently, and no cannabis-based medicine has been shown to prevent that.

Beyond that, the usual profile applies: drowsiness, dizziness, dry mouth, impaired concentration and driving impairment from THC-containing products. Many people with arthritis are older and take several medicines, which raises the risk of interactions and of falls; a specialist should take that seriously rather than treating age as incidental. Personal or family history of psychosis, unstable mental illness, significant cardiovascular disease, pregnancy and breastfeeding all count against treatment.

If you want to take this further

The useful next step is a proper assessment, not a better list. Gather your diagnosis, the treatments you have already tried and what happened with each, and your current medicines — that is what a specialist needs in order to give you a straight answer.

The consultation itself, and what happens after it, is set out in What is the process to get a medical cannabis prescription? If arthritis-related pain is not the only thing you are being treated for, say so early: other conditions and other medicines change the assessment.

Frequently asked questions

Can I get medical cannabis for arthritis in the UK?

Arthritis-related pain is assessed by private specialists where standard treatment has not given adequate relief. No cannabis-based medicine is licensed in the UK for arthritis, and NICE recommends against cannabis-based medicines for chronic pain outside a clinical trial.

Does medical cannabis treat the arthritis itself?

No. It is considered for symptom relief only. Rheumatoid arthritis and other inflammatory arthritis need disease-modifying drugs to prevent joint damage, and a cannabis-based medicine is not a substitute for them. You should stay under rheumatology care.

Is there any trial evidence in arthritis?

One small randomised controlled trial in rheumatoid arthritis, published in Rheumatology in 2006, found improvements in pain and morning stiffness against placebo over five weeks in 58 patients. It was preliminary and has not been followed by large confirmatory trials. Evidence in osteoarthritis is weaker.

Can I take it with my current arthritis medicines?

That depends on what you take. Your prescriber will review all of your medicines for interactions and for combined sedation, and will normally coordinate with your rheumatology team rather than working around it.

Sources and further reading

Every factual statement on this page is drawn from the following public sources. Links open in a new tab and are not affiliated with Flora House.

  1. Blake DR, et al. Preliminary assessment of the efficacy, tolerability and safety of a cannabis-based medicine (Sativex) in the treatment of pain caused by rheumatoid arthritis. Rheumatology (2006)
  2. NICE guideline NG226: Osteoarthritis in over 16s
  3. NHS: Arthritis
  4. NICE guideline NG144: Cannabis-based medicinal products
  5. NHS: Medical cannabis (and cannabis oils)
  6. House of Commons Library briefing CBP-8355: Medical use of cannabis
  7. MHRA: The supply, manufacture, importation and distribution of unlicensed cannabis-based products for medicinal use

Patient guide · Written by the Flora House editorial team · Last reviewed: 31 August 2026